Alzheimer's & Dementia
Plasma GFAP modifies the association of depressive symptoms with cognitive function: A population-based study

Cross-sectional study of 11,059 peopleBiomarkers
Declared no competing interests
- GFAP
- Depression
- Cognitive impairment
- Glial fibrillary acidic protein
- Memory and Executive Screening
- Humans
